Analysts expect Kronos Worldwide, Inc. (NYSE:KRO) to post sales of $430.28 million for the current fiscal quarter, Zacks Investment Research reports. Two analysts have issued estimates for Kronos Worldwide’s earnings, with the highest sales estimate coming in at $446.00 million and the lowest estimate coming in at $414.56 million. Kronos Worldwide posted sales of $410.30 million during the same quarter last year, which suggests a positive year over year growth rate of 4.9%. The company is expected to announce its next earnings results on Wednesday, November 6th.
On average, analysts expect that Kronos Worldwide will report full-year sales of $1.73 billion for the current year, with estimates ranging from $1.68 billion to $1.77 billion. For the next fiscal year, analysts expect that the firm will post sales of $1.84 billion, with estimates ranging from $1.76 billion to $1.93 billion. Zacks’ sales calculations are an average based on a survey of sell-side research firms that follow Kronos Worldwide.
Kronos Worldwide (NYSE:KRO) last posted its earnings results on Wednesday, August 7th. The specialty chemicals company reported $0.25 earnings per share for the quarter, missing the Zacks’ consensus estimate of $0.31 by ($0.06). The firm had revenue of $484.50 million for the quarter, compared to analysts’ expectations of $465.00 million. Kronos Worldwide had a return on equity of 13.56% and a net margin of 6.93%. The business’s revenue for the quarter was up 2.7% on a year-over-year basis. During the same quarter in the prior year, the company posted $0.67 earnings per share.
In other news, insider Andrew B. Nace acquired 6,000 shares of the stock in a transaction on Friday, August 9th. The stock was bought at an average price of $11.21 per share, with a total value of $67,260.00. Following the completion of the transaction, the insider now directly owns 4,475 shares of the company’s stock, valued at $50,164.75. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through this hyperlink. Also, Vice Chairman Robert D. Graham acquired 5,000 shares of the stock in a transaction on Friday, August 9th. The stock was purchased at an average cost of $10.75 per share, with a total value of $53,750.00. Following the transaction, the insider now directly owns 16,000 shares of the company’s stock, valued at $172,000. The disclosure for this purchase can be found here. Insiders acquired 13,000 shares of company stock valued at $142,010 in the last ninety days. 0.09% of the stock is owned by corporate insiders.
Several institutional investors have recently added to or reduced their stakes in the company. Alps Advisors Inc. increased its stake in shares of Kronos Worldwide by 5.0% during the first quarter. Alps Advisors Inc. now owns 28,886 shares of the specialty chemicals company’s stock valued at $405,000 after purchasing an additional 1,384 shares in the last quarter. Pearl River Capital LLC grew its stake in shares of Kronos Worldwide by 357.5% during the first quarter. Pearl River Capital LLC now owns 4,012 shares of the specialty chemicals company’s stock valued at $56,000 after buying an additional 3,135 shares during the last quarter. Northern Trust Corp grew its stake in shares of Kronos Worldwide by 0.5% during the fourth quarter. Northern Trust Corp now owns 363,090 shares of the specialty chemicals company’s stock valued at $4,182,000 after buying an additional 1,783 shares during the last quarter. Metropolitan Life Insurance Co. NY grew its stake in shares of Kronos Worldwide by 378.2% during the fourth quarter. Metropolitan Life Insurance Co. NY now owns 7,972 shares of the specialty chemicals company’s stock valued at $92,000 after buying an additional 6,305 shares during the last quarter. Finally, Geode Capital Management LLC grew its stake in shares of Kronos Worldwide by 5.2% during the fourth quarter. Geode Capital Management LLC now owns 240,081 shares of the specialty chemicals company’s stock valued at $2,764,000 after buying an additional 11,864 shares during the last quarter. Institutional investors own 20.40% of the company’s stock.
Shares of KRO stock traded down $0.20 on Friday, reaching $10.43. 329,193 shares of the stock were exchanged, compared to its average volume of 303,360. The firm’s 50 day moving average price is $13.56. The company has a market capitalization of $1.22 billion, a PE ratio of 5.89, a PEG ratio of 0.72 and a beta of 1.98. The company has a current ratio of 4.94, a quick ratio of 2.98 and a debt-to-equity ratio of 0.61. Kronos Worldwide has a one year low of $10.31 and a one year high of $21.06.
The company also recently disclosed a quarterly dividend, which will be paid on Saturday, September 14th. Shareholders of record on Thursday, September 5th will be given a $0.18 dividend. This represents a $0.72 annualized dividend and a yield of 6.90%. The ex-dividend date of this dividend is Wednesday, September 4th. Kronos Worldwide’s dividend payout ratio (DPR) is 40.68%.
About Kronos Worldwide
Kronos Worldwide, Inc produces and markets titanium dioxide pigments (TiO2) in Europe, North America, the Asia Pacific, and internationally. It produces TiO2 in two crystalline forms, rutile and anatase to impart whiteness, brightness, opacity, and durability for various products, including paints, coatings, plastics, paper, fibers, and ceramics, as well as for various specialty products, such as inks, foods, and cosmetics.
Further Reading: Insider Trading – What You Need to Know
For more information about research offerings from Zacks Investment Research, visit Zacks.com
Receive News & Ratings for Kronos Worldwide Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Kronos Worldwide and related companies with MarketBeat.com's FREE daily email newsletter.